Aristeia Capital L.L.C. Purchases Shares of 17,810 Sotera Health Company $SHC

Key Points

• Aristeia Capital has invested $208,000 in **Sotera Health Company**, acquiring 17,810 shares during the first quarter, highlighting institutional interest in the stock.
• Sotera Health reported a quarterly **EPS of $0.20**, beating estimates, with revenue of **$294.34 million**, showcasing a 6.4% increase year-over-year.
• Equities research analysts have published a consensus rating of **"Moderate Buy"** for Sotera Health, with a price target of **$16.00** and four analysts recommending a Buy rating.

Aristeia Capital L.L.C. bought a new position in Sotera Health Company (NASDAQ:SHC - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 17,810 shares of the company's stock, valued at approximately $208,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Two Seas Capital LP lifted its holdings in Sotera Health by 14.7% in the 1st quarter. Two Seas Capital LP now owns 3,321,136 shares of the company's stock worth $38,724,000 after purchasing an additional 425,000 shares during the last quarter. Irenic Capital Management LP lifted its holdings in Sotera Health by 7.2% in the 1st quarter. Irenic Capital Management LP now owns 3,117,226 shares of the company's stock worth $36,347,000 after purchasing an additional 208,063 shares during the last quarter. TPG GP A LLC acquired a new stake in Sotera Health in the 1st quarter worth approximately $79,126,000. Khrom Capital Management LLC lifted its holdings in Sotera Health by 55.4% in the 1st quarter. Khrom Capital Management LLC now owns 567,834 shares of the company's stock worth $6,621,000 after purchasing an additional 202,448 shares during the last quarter. Finally, Ananym Capital Management LP lifted its holdings in Sotera Health by 29.3% in the 1st quarter. Ananym Capital Management LP now owns 1,292,779 shares of the company's stock worth $15,074,000 after purchasing an additional 292,779 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SHC has been the subject of a number of research analyst reports. Barclays reiterated an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 16th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Sotera Health has an average rating of "Moderate Buy" and an average target price of $16.00.

Sotera Health Stock Performance

Shares of SHC stock traded down $0.07 during trading hours on Friday, reaching $16.05. 2,486,837 shares of the company's stock were exchanged, compared to its average volume of 2,438,050. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $16.99. The stock has a market capitalization of $4.56 billion, a P/E ratio of 200.65 and a beta of 1.83. The business has a fifty day moving average price of $13.78 and a 200-day moving average price of $12.42. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. The business had revenue of $294.34 million for the quarter, compared to analysts' expectations of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.Sotera Health's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Analysts predict that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Insider Activity

In other news, Director Pincus & Co. Warburg sold 12,000,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the sale, the director directly owned 61,822,952 shares in the company, valued at approximately $934,144,804.72. The trade was a 16.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the sale, the director owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. This represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 20,126,611 shares of company stock worth $304,273,888. Company insiders own 55.12% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.